Virtus ETF Advisers LLC Repare Therapeutics Inc. Transaction History

Virtus ETF Advisers LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$9.32 - $15.06 $24,399 - $39,427	-2,618 Reduced 27.77%	6,808 $66,000
Q4 2022 Feb 14, 2023	BUY	$12.5 - $18.13 $22,362 - $32,434	1,789 Added 23.43%	9,426 $138,000
Q3 2022 Nov 14, 2022	BUY	$11.57 - $15.59 $590 - $795	51 Added 0.67%	7,637 $93,000
Q2 2022 Aug 12, 2022	SELL	$8.45 - $14.84 $2,577 - $4,526	-305 Reduced 3.87%	7,586 $106,000
Q1 2022 May 16, 2022	SELL	$11.38 - $21.88 $5,280 - $10,152	-464 Reduced 5.55%	7,891 $112,000
Q4 2021 Feb 14, 2022	BUY	$19.66 - $28.11 $36,823 - $52,650	1,873 Added 28.9%	8,355 $176,000
Q3 2021 Nov 15, 2021	SELL	$25.71 - $35.24 $8,895 - $12,193	-346 Reduced 5.07%	6,482 $170,000
Q2 2021 Aug 10, 2021	SELL	$30.1 - $34.85 $23,598 - $27,322	-784 Reduced 10.3%	6,828 $213,000
Q1 2021 May 17, 2021	BUY	$25.89 - $44.46 $3,702 - $6,357	143 Added 1.91%	7,612 $234,000
Q4 2020 Feb 12, 2021	BUY	$23.42 - $39.5 $174,923 - $295,025	7,469 New	7,469 $256,000

34.8M

51K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $51.2M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.